RIPK1, GST-Th-Tag Recombinant

Catalog #
40371
$420 *
Size: 10 µg
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

Recombinant human RIPK1 (receptor-interacting serine-threonine kinase 1), encompassing amino acids 1-327 containing the protein kinase domain. This construct contains an N-terminal GST-tag. A short peptide placed between GST and the protein includes a Thrombin Cleavage Site to facilitate removal of the GST portion. The recombinant protein was affinity purified.

This product has been cited 1 time.

Synonyms
Receptor-interacting serine/threonine-protein kinase, Cell death protein RIP, Receptor-interacting protein 1, RIP-1, RIPK1, RIP, RIP1
Product Info
Storage and Usage
Citations1
Species
Human
Construct
RIPK1 (GST-Th-1-327)
Host Species/Expression System
Sf9
Purity

≥90%

Format

Aqueous buffer solution

Formulation
40 mM Tris-HCl, pH 8.0, 110 mM NaCl, 2.2 mM KCl, and 20% Glycerol.
MW
64 kDa
Amino Acids
1-327
Genbank #
NM_003804
UniProt #
Q13546
Tag(s)
N-terminal GST-Th-Tag
Background
RIPK1 or Receptor Interacting Protein Kinase 1 is a serine/threonine kinase that was originally identified as interacting with the cytoplasmic domain of FAS. RIPK1 has been deemed as an important element in the signal transduction machinery that mediates programmed cell death. RIPK1 has been shown to interact with TRADD, TRAF1 TRAF2 and TRAF3 and TRADD can act as an adaptor protein to recruit RIPK1 to the TNFR1 complex in a TNF-dependent process. TNFα is capable of activating the noncanonical NF-κB pathway, but this activation of this pathway is negatively regulated by RIPK1.
References

1. Hsu, H. et al., Immunity 4: 387-396, 1996.
2. Kim, J Y. et al., J Cell Sci. 2011 Feb 15;124(Pt 4):647-56.

Application References:

1. The Bcr-Abl inhibitor GNF-7 inhibits necroptosis and ameliorates acute kidney injury by targeting RIPK1 and RIPK3 kinases